AK Medical Holdings Limited (HKG:1789)
Hong Kong
· Delayed Price · Currency is HKD 5.87
+0.11 (1.91%)
Mar 10, 2026, 11:43 AM HKT
AK Medical Holdings Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 6,457 | 5,445 | 7,023 | 10,923 | 7,364 | 15,015 | Upgrade
|
| Market Cap Growth | 12.78% | -22.47% | -35.70% | 48.34% | -50.96% | 62.45% | Upgrade
|
| Enterprise Value | 4,957 | 4,655 | 6,173 | 9,917 | 6,411 | 14,035 | Upgrade
|
| Last Close Price | 5.76 | 4.79 | 6.12 | 9.49 | 6.36 | 12.93 | Upgrade
|
| PE Ratio | 20.22 | 18.68 | 35.01 | 47.19 | 64.77 | 40.26 | Upgrade
|
| Forward PE | 15.75 | 32.47 | 32.47 | 32.47 | 32.47 | 28.97 | Upgrade
|
| PS Ratio | 4.26 | 3.80 | 5.83 | 9.18 | 7.88 | 12.21 | Upgrade
|
| PB Ratio | 2.16 | 1.94 | 2.67 | 4.31 | 2.95 | 6.19 | Upgrade
|
| P/TBV Ratio | 2.32 | 2.10 | 2.91 | 4.72 | 3.30 | 6.90 | Upgrade
|
| P/FCF Ratio | 14.43 | 17.16 | - | 75.65 | 50.90 | 105.35 | Upgrade
|
| P/OCF Ratio | 10.57 | 11.34 | 187.86 | 39.78 | 33.97 | 61.60 | Upgrade
|
| PEG Ratio | - | 0.77 | 0.77 | 0.77 | 0.77 | 0.77 | Upgrade
|
| EV/Sales Ratio | 3.27 | 3.25 | 5.12 | 8.34 | 6.86 | 11.42 | Upgrade
|
| EV/EBITDA Ratio | 10.72 | 11.58 | 19.84 | 29.21 | 33.30 | 28.05 | Upgrade
|
| EV/EBIT Ratio | 14.34 | 14.54 | 26.49 | 36.80 | 52.53 | 31.28 | Upgrade
|
| EV/FCF Ratio | 11.07 | 14.67 | - | 68.68 | 44.32 | 98.48 | Upgrade
|
| Debt / Equity Ratio | 0.06 | 0.04 | 0.04 | 0.02 | 0.02 | 0.01 | Upgrade
|
| Debt / EBITDA Ratio | 0.36 | 0.25 | 0.28 | 0.12 | 0.24 | 0.06 | Upgrade
|
| Debt / FCF Ratio | 0.38 | 0.33 | - | 0.30 | 0.35 | 0.22 | Upgrade
|
| Net Debt / Equity Ratio | -0.50 | -0.33 | -0.27 | -0.45 | -0.39 | -0.43 | Upgrade
|
| Net Debt / EBITDA Ratio | -3.39 | -2.31 | -2.29 | -3.35 | -5.12 | -2.08 | Upgrade
|
| Net Debt / FCF Ratio | -3.35 | -2.92 | 4.31 | -7.88 | -6.81 | -7.31 | Upgrade
|
| Asset Turnover | 0.41 | 0.43 | 0.38 | 0.39 | 0.30 | 0.52 | Upgrade
|
| Inventory Turnover | 1.06 | 0.99 | 0.84 | 1.01 | 0.67 | 1.09 | Upgrade
|
| Quick Ratio | 2.88 | 2.69 | 2.65 | 3.66 | 2.84 | 3.52 | Upgrade
|
| Current Ratio | 3.50 | 3.65 | 3.96 | 4.73 | 3.95 | 4.55 | Upgrade
|
| Return on Equity (ROE) | 11.31% | 10.89% | 7.86% | 9.58% | 4.55% | 19.88% | Upgrade
|
| Return on Assets (ROA) | 5.86% | 5.93% | 4.58% | 5.54% | 2.42% | 11.78% | Upgrade
|
| Return on Invested Capital (ROIC) | 19.89% | 14.66% | 11.17% | 16.47% | 7.09% | 35.06% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.20% | 11.00% | 8.40% | 10.20% | 4.70% | 17.90% | Upgrade
|
| Earnings Yield | 5.01% | 5.35% | 2.86% | 2.12% | 1.54% | 2.48% | Upgrade
|
| FCF Yield | 6.93% | 5.83% | -2.35% | 1.32% | 1.97% | 0.95% | Upgrade
|
| Dividend Yield | 1.24% | 1.50% | 0.73% | 0.63% | 0.39% | 0.31% | Upgrade
|
| Payout Ratio | 25.27% | 16.83% | 33.78% | 11.70% | 39.62% | 24.01% | Upgrade
|
| Buyback Yield / Dilution | -0.11% | 0.05% | -0.15% | 0.28% | -1.21% | -4.61% | Upgrade
|
| Total Shareholder Return | 1.13% | 1.55% | 0.58% | 0.91% | -0.82% | -4.31% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.